瘧疾診斷市場 - 按產品、技術、最終用途 - 全球預測

由於瘧疾盛行率不斷上升，特別是在撒哈拉以南非洲、東南亞和拉丁美洲部分地區，預計從 2024 年到 2032 年，瘧疾診斷市場規模的複合年成長率將達到 5%。根據世界衛生組織估計，到 2022 年，全球將有 2.49 億例瘧疾病例和 608,000 例與瘧疾相關的死亡。有效診斷工具的需求源自於及時識別和治療瘧疾病例以預防嚴重併發症和降低死亡率的必要性。隨著醫療保健基礎設施的改善，診斷技術變得更加容易取得。

快速診斷測試 RDT 等創新無需專用設備或電力即可提供快速、準確的結果，徹底改變了資源有限環境中的瘧疾診斷。聚合酶鍊式反應 PCR 和環介導等溫擴增 LAMP 等分子診斷方法的發展也為檢測瘧疾寄生蟲提供了更高的靈敏度和特異性，進一步推動了市場成長。

瘧疾診斷產業分為產品、技術、最終用途和地區。

根據產品，儀器領域的市場價值預計將在 2024 年至 2032 年期間出現顯著的複合年成長率，這得益於對提供先進和自動化解決方案以提高瘧疾檢測效率和準確性的強烈需求。自動顯微鏡系統、核酸擴增分析儀和高通量篩選平台等儀器可簡化診斷過程，同時縮短週轉時間並提高實驗室和醫療機構的通量。

由於顯微鏡技術領域作為檢測瘧原蟲的可靠且廣泛使用的方法的既定作用，到 2032 年，其瘧疾診斷市場將顯著成長。血液抹片顯微鏡檢查仍然是瘧疾診斷的基石，因為它具有高度特異性並且能夠識別不同種類的瘧原蟲寄生蟲。顯微鏡技術的快速進步，例如數位顯微鏡和自動影像分析系統，以提高瘧疾診斷的準確性和效率，也將推動該領域的成長。

亞太地區瘧疾診斷產業將在 2024 年至 2032 年期間呈現令人印象深刻的成長。旨在消除和控制瘧疾的政府措施和國際資金的增加將大大增加對準確和快速診斷方法的需求。此外，整個地區醫療保健基礎設施的擴展和實驗室能力的提高正在促進更好地獲得先進的診斷技術。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 瘧疾盛行率增加
    • 診斷技術的進步
    • 提高預防瘧疾的意識和教育
    • 發展中國家擴大採用即時檢測
  • 產業陷阱與挑戰
    • 嚴格的監管場景
• 成長潛力分析
• 技術景觀
• 監管環境
• 波特的分析
• PESTEL分析

第 4 章：競爭格局

• 介紹
• 公司市佔率分析
• 競爭定位矩陣
• 戰略展望矩陣

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

• 主要趨勢
• 儀器
• 試劑盒和試劑

第 6 章：市場估計與預測：按技術分類，2021 - 2032 年

• 主要趨勢
• 顯微鏡檢查
• 快速診斷測試
• 分子診斷測試
  • 常規PCR
  • 即時定量PCR
• 其他技術

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

• 主要趨勢
• 診所
• 醫院
• 診斷中心
• 其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 9 章：公司簡介

• Abbott Laboratories
• Access Bio
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• Danaher corporation
• F. Hoffmann-La Roche Ltd.
• Nikon Corporation
• Premier Medical Corporation Private Limited
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.

Malaria diagnostics market size is projected to witness 5% CAGR from 2024 - 2032, driven by the increasing prevalence of malaria, particularly in sub-Saharan Africa, Southeast Asia, and parts of Latin America. As per WHO, in 2022, it is estimated that there were 249 million malaria cases and 608,000 malaria-related deaths worldwide. The demand for effective diagnostic tools stems from the necessity to promptly identify and treat malaria cases to prevent severe complications and reduce mortality rates. With the improving healthcare infrastructures, diagnostic technologies have become more accessible.

Innovations, such as rapid diagnostic tests RDTs, which provide quick and accurate results without the need for specialized equipment or electricity, have revolutionized malaria diagnosis in resource-limited settings. The development of molecular diagnostic methods, such as polymerase chain reaction PCR and loop-mediated isothermal amplification LAMP are also offering higher sensitivity and specificity in detecting malaria parasites, further driving the market growth.

The malaria diagnostics industry is classified into product, technology, end-use and region.

Based on product, the market value from the instrument segment is anticipated to observe a significant CAGR during 2024-2032 favored by the strong need for providing advanced and automated solutions that enhance the efficiency and accuracy of malaria testing. Instruments, such as automated microscopy systems, nucleic acid amplification analyzers, and high-throughput screening platforms streamline the diagnostic process while reducing turnaround times and improving throughput in laboratories and healthcare settings.

Malaria diagnostics market from the microscopy technology segment is set to witness notable growth through 2032 due to its established role as a reliable and widely used method for detecting malaria parasites. Microscopic examination of blood smears remains a cornerstone in malaria diagnosis for offering high specificity and the ability to identify different species of Plasmodium parasites. Rapid advancements in microscopy techniques, such as digital microscopy and automated image analysis systems to enhance the accuracy and efficiency of malaria diagnosis will also drive the segment growth.

Asia Pacific malaria diagnostics industry will showcase impressive growth over 2024-2032. Increased government initiatives and international funding aimed at malaria elimination and control programs will significantly boost the demand for accurate and rapid diagnostic methods. Additionally, the expansion of healthcare infrastructure and improvements in laboratory capabilities across the region are facilitating better access to advanced diagnostic technologies.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of malaria
    • 3.2.1.2 Advancement in diagnostic technologies
    • 3.2.1.3 Rising awareness and education regarding malaria prevention
    • 3.2.1.4 Increasing adoption of point-of-care testing in developing countries
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory scenario
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Instruments
• 5.3 Kits & reagents

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Microscopy
• 6.3 Rapid diagnostic tests
• 6.4 Molecular diagnostic tests
  • 6.4.1 Conventional PCR
  • 6.4.2 Real-time PCR
• 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Clinics
• 7.3 Hospitals
• 7.4 Diagnostic centers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Access Bio
• 9.3 Becton, Dickinson and Company
• 9.4 Bio-Rad Laboratories, Inc.
• 9.5 Danaher corporation
• 9.6 F. Hoffmann-La Roche Ltd.
• 9.7 Nikon Corporation
• 9.8 Premier Medical Corporation Private Limited
• 9.9 Siemens Healthineers AG
• 9.10 Thermo Fisher Scientific Inc.